TRex Bio, Inc. — Form 8-K
Filed October 13, 2026 · analyzed by the 8-K Agent
8-K
— Neutral
significance 12/100
What the filing says
TRex Bio, Inc. filed its Fourth Amended and Restated Certificate of Incorporation on October 13, 2026, and adopted Second Amended and Restated Bylaws. The filings establish standard corporate governance: 225M authorized common shares and 25M preferred shares; classified board with 3-15 directors removable only for cause by 66⅔% vote; supermajority (66⅔%) vote required to amend key provisions; Delaware Court of Chancery as exclusive forum for covered claims; and detailed advance notice bylaws for stockholder nominations (90-120 days prior to annual meeting). No material business changes, financing, or operational matters are disclosed.
Why this rating
Routine corporate governance restructuring. Certificate and bylaw amendments are standard periodic filings with no disclosed financial, operational, or strategic impact. No counterparties, transaction values, or business developments mentioned.
See more from October 13, 2026.
EDGAR·FLOW summarizes public SEC EDGAR filings with automated analysis. Materiality scores and stock-impact predictions are algorithmically generated and are not investment advice. Always verify against the source filing on SEC.gov.